#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Internal Medicine - Issue 4/2021

Editorial

191

Použití léků vyvinutých pro jiné indikace v léčbě infekce covid-19

Main Topic

195

Targeted and biological drugs in the treatment of inflammatory rheumatic diseases

Karel Pavelka

201

Treating inflammatory bowel diseases in the 21st century: individualized therapy and telemedicine

Milan Lukáš

206

Biologic therapy for dyslipidemia

David Karásek

Original Contributions

212

Monitoring the dynamics of clinical and laboratory markers of chronic heart failure during 12 months of sacubitril/valsartan treatment

Jana Čepelová, Marek Malý, Josef Daněk, Martin Malý

Review Articles

218

Importance and efficiency of blood pressure control not only in type 2 diabetes patients

Veronika Vejtasová, Jana Urbanová, Ludmila Brunerová, Michala Lustigová, Michael Jenšovský, Barbora Prýmková, Sabina Pálová, Jan Brož

224

Giant cell arteritis: controversial issues

Štefan Alušík

230

Chronic obstructive pulmonary disease: diagnosis and treatment of stable phase of disease; personalized treatment approach using phenotype features of the disease Summary of the 2020–2021 Czech Pneumological and Phthiseological Society position paper

doc. MUDr. Kristián Brat, Ph.D., Jaromír Zatloukal, Kateřina Neumannová, MUDr. Eva Voláková, Ph.D., Ondřej Kudela, Michal Kopecký, Marek Plutinský, Vladimír Koblížek

Case reports

240

Thymoma – disease of many faces

Kateřina Pokorná, Vladimír Kojecký

244

An effective communication between the physician and the patient in an early intervention of hypertension and dyslipidemia

Barbora Nussbaumerová

Internal Medicine

Issue 4

2021 Issue 4

Most read in this issue

#ADS_BOTTOM_SCRIPTS#